Caribou Biosciences (CRBU) EBITDA Margin Growth (3y) (2023 - 2026)
Caribou Biosciences (CRBU) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Caribou Biosciences |
177.34 Mn |
59.72 Mn |
- |
-27,347.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-27,347.00 |
| Dec 31, 2025 |
4,515.00 |
| Sep 30, 2025 |
-43,041.00 |
| Jun 30, 2025 |
-138,459.00 |
| Mar 31, 2025 |
-95,099.00 |
| Dec 31, 2024 |
-100,703.00 |
| Sep 30, 2024 |
-113,151.00 |
| Jun 30, 2024 |
-11,858.00 |
| Mar 31, 2024 |
-88,237.00 |
| Dec 31, 2023 |
60,446.00 |
| Sep 30, 2023 |
64,528.00 |
| Jun 30, 2023 |
-77,034.00 |
| Mar 31, 2023 |
-16,519.00 |
